Farallon Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,442,299
| Closed | -$96.1M | – | 197 |
|
|
2023
Q2 | $96.1M | Buy |
2,442,299
+1,957,500
| +404% | +$77M | 0.48% | 48 |
|
|
2023
Q1 | $11.8M | Sell |
484,799
-977,201
| -67% | -$23.8M | 0.06% | 93 |
|
|
2022
Q4 | $31.3M | Buy |
1,462,000
+145,000
| +11% | +$3.1M | 0.18% | 71 |
|
|
2022
Q3 | $23.6M | Buy |
+1,317,000
| New | +$23.6M | 0.13% | 93 |
|
|
2021
Q1 | – | Sell |
-754,740
| Closed | -$5.22M | – | 251 |
|
|
2020
Q4 | $5.22M | Hold |
754,740
| – | – | 0.03% | 119 |
|
|
2020
Q3 | $4.26M | Buy |
754,740
+4,740
| +0.6% | +$26.7K | 0.03% | 109 |
|
|
2020
Q2 | $3.83M | Buy |
+750,000
| New | +$3.83M | 0.03% | 110 |
|